Takeaways from the Milwaukee HPC User Forum

September 20, 2017Uncategorized

Article by Merle Giles, September 19, 2017 A breath of fresh air came from Graham Anthony who spoke about the pursuit of sustainable healthcare through personalized medicine. The Biovista website calls it ‘drug repositioning’ when HPC drives the ability to more effectively and quickly combine patient and general biomedical data to transform medicine. The key … Read More

BioWorld: Biovista lands new backing for AI-driven personalized medicine ‘Prodigy’

August 15, 2017Media coverage

Article By Michael Fitzhug, Staff Writer BioWorld, Monday, August 14, 2017 Drug repositioning specialist Biovista Inc. has tapped Hewlett Packard Enterprise Co. (HPE) to add greater computing power to Project Prodigy, a personalized medicine platform that leverages artificial intelligence (AI) to help doctors identify novel drugs for hard-to-treat patients. HPE, a spin-off of HP Inc. … Read More

Biovista expands Project Prodigy collaborations in personalized medicine

August 11, 2017Press Releases

Biovista and Hewlett Packard Enterprise to collaborate on next generation AI and Big Data Analytics to advance real-world personalized medicine at community hospital settings. CHARLOTTESVILLE, Va., Aug. 10, 2017 /PRNewswire/ — Biovista announced today that it is collaborating with HPE to advance Biovista’s Project Prodigy Big Data AI healthcare platform applied in the personalized medicine … Read More

Biomarkers in Biovista Vizit

June 27, 2017Vizit Blog

Vizit now indexes biomarkers! Biomarkers are widely employed as biochemical indicators of health and disease states and processes. Their usage spans a wide range of applications including disease prevention, monitoring and assessing the progress of a therapeutic regimen and the appearance of adverse drug reactions and drug interactions. In order to monitor physiological and disease … Read More